M., Chamoun
A., Forget
I., Chabot
M., Schnitzer
L., Blais
Article History
Received: 2 June 2021
Accepted: 3 February 2022
First Online: 14 February 2022
Declarations
:
: According to the institutional guidelines, this study was approved by the Human Scientific and Ethics Committee of the <i>Centre Intégré Universitaire de Santé et de Services Sociaux du Nord-de-l’Île-de-Montréal</i> (reference number: 2019–1629). All reMed participants signed an informed consent form allowing the use of their drug data for future studies. For reMed’s participants aged less than 16 years, an informed consent was obtained from their parent or legal guardian.
: Not applicable since no human identity revealing data is used in the study.
: We declare no competing interests.